ABT vs. PEN: Abbott Laboratories vs. Penumbra Stock Comparison

November 11, 2026

How do Abbott Laboratories (ABT) and Penumbra (PEN) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Abbott Laboratories (ABT) and Penumbra (PEN) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.

Company profile comparison for Abbott Laboratories (ABT) and Penumbra (PEN)
Profile Item	ABT	PEN
Name	Abbott Laboratories	Penumbra Inc.
Country/Region	United States	United States
GICS Sector	Health Care	Health Care
GICS Industry Group	Health Care Equipment & Services	Health Care Equipment & Services
GICS Industry	Health Care Equipment & Supplies	Health Care Equipment & Supplies
GICS Sub-Industry	Health Care Equipment	Health Care Equipment
Market Capitalization	190.39 billion USD	12.58 billion USD
Currency	USD	USD
Exchange	NYSE	NYSE
Listing Date	March 17, 1980	September 18, 2015
Security Type	Common Stock	Common Stock

Price Performance

Cumulative Growth

ABT

PEN

GSPC

Abbott Laboratories (ABT) vs. Penumbra (PEN), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…

Trailing total returns for Abbott Laboratories (ABT) and Penumbra (PEN). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…

Calendar-year total returns for Abbott Laboratories (ABT) and Penumbra (PEN). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Total Return (1Y)	-10.78%	20.52%
Total Return (3Y, Annualized)	7.79%	20.38%
Total Return (5Y, Annualized)	-0.79%	3.15%

Risk Profile

Drawdown History

ABT

PEN

GSPC

Abbott Laboratories (ABT) vs. Penumbra (PEN), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…

Distribution of monthly total returns for Abbott Laboratories (ABT) and Penumbra (PEN). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Volatility (1Y, Annualized)	28.48%	19.78%
Beta (5Y)	0.53	0.68
Max Drawdown (5Y)	-39.64%	-59.60%
Avg. Volume (3M)	8.74M	348.64K

Risk-Adjusted Performance

Risk-Return Positioning

ABT and PEN are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Sharpe Ratio (1Y)	-0.53	0.82
Sortino Ratio (1Y)	-0.76	1.56

Profitability

ROE (TTM)

Both Abbott Laboratories (ABT) at 9.14% and Penumbra (PEN) at 10.67% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

ABT

Health Care Equipment & Services industry group

9.14%

Max: 47.61%
Q3: 14.36%
ABT: 9.14%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

PEN

Health Care Equipment & Services industry group

10.67%

Max: 47.61%
Q3: 14.36%
PEN: 10.67%
Median: 5.45%
Q1: -10.67%
Min: -47.01%

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their ROE against the Health Care Equipment & Services industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both Abbott Laboratories (ABT) at 9.75% and Penumbra (PEN) at 10.06% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

ABT

Health Care Equipment & Services industry group

9.75%

Max: 29.35%
ABT: 9.75%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

PEN

Health Care Equipment & Services industry group

10.06%

Max: 29.35%
PEN: 10.06%
Q3: 9.33%
Median: 2.18%
Q1: -6.29%
Min: -28.46%

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their net margin against the Health Care Equipment & Services industry group benchmark.

Operating Margin (TTM)

Both Abbott Laboratories (ABT) at 11.66% and Penumbra (PEN) at 12.37% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.

ABT

Health Care Equipment & Services industry group

11.66%

Max: 35.43%
Q3: 14.14%
ABT: 11.66%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

PEN

Health Care Equipment & Services industry group

12.37%

Max: 35.43%
Q3: 14.14%
PEN: 12.37%
Median: 6.81%
Q1: -0.28%
Min: -16.29%

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their operating margin against the Health Care Equipment & Services industry group benchmark.

Profitability Metrics

Profitability metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
ROE (TTM)	9.14%	10.67%
ROA (TTM)	4.90%	6.28%
Net Margin (TTM)	9.75%	10.06%
Operating Margin (TTM)	11.66%	12.37%
Gross Margin (TTM)	57.17%	67.99%

Growth

Revenue Growth

Both Abbott Laboratories (ABT) at 5.67% and Penumbra (PEN) at 17.50% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their Revenue Growth across different time periods.

EPS Growth

Penumbra (PEN) at 1,155.56% delivers above-range EPS growth, while Abbott Laboratories (ABT) at -51.31% falls into the bottom quartile — a wide split in earnings momentum.

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Revenue Growth (YoY)	5.67%	17.50%
Revenue Growth (3Y CAGR)	0.51%	18.33%
EPS Growth (YoY)	-51.31%	1,155.56%
EPS Growth (3Y CAGR)	-1.65%	--

Financial Strength

Current Ratio (MRQ)

Abbott Laboratories (ABT) at 1.46 keeps current ratio within its industry’s typical mid-range, while Penumbra (PEN) at 5.89 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.

ABT

Health Care Equipment & Services industry group

1.46

Max: 7.59
Q3: 4.00
Median: 1.98
ABT: 1.46
Q1: 1.37
Min: 0.30

PEN

Health Care Equipment & Services industry group

5.89

Max: 7.59
PEN: 5.89
Q3: 4.00
Median: 1.98
Q1: 1.37
Min: 0.30

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their current ratio against the Health Care Equipment & Services industry group benchmark.

Debt / Equity (MRQ)

Penumbra (PEN) at 0.13 keeps leverage in the lower industry quartile, while Abbott Laboratories (ABT) at 0.61 runs a more typical debt-to-equity mix.

ABT

Health Care Equipment & Services industry group

0.61

Max: 1.88
Q3: 0.91
ABT: 0.61
Median: 0.58
Q1: 0.16
Min: 0.00

PEN

Health Care Equipment & Services industry group

0.13

Max: 1.88
Q3: 0.91
Median: 0.58
Q1: 0.16
PEN: 0.13
Min: 0.00

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their debt-to-equity ratio against the Health Care Equipment & Services industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Current Ratio (MRQ)	1.46	5.89
Debt / Equity (MRQ)	0.61	0.13
Net Debt / EBITDA	2.37	-2.22

Dividends

Dividend Yield (TTM)

Penumbra (PEN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a yield of 2.22%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

2.22%

ABT: 2.22%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PEN

Health Care Equipment & Services industry group

0.00%

PEN: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their dividend yield against the Health Care Equipment & Services industry group benchmark.

Dividend Payout Ratio (TTM)

Penumbra (PEN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Abbott Laboratories (ABT) reports a payout of 92.54%, ranking against industry peers normally.

ABT

Health Care Equipment & Services industry group

92.54%

ABT: 92.54%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

PEN

Health Care Equipment & Services industry group

0.00%

PEN: 0.00%
Max: 0.00%
Q3: 0.00%
Median: 0.00%
Q1: 0.00%
Min: 0.00%

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their payout ratio against the Health Care Equipment & Services industry group benchmark.

Dividend Metrics

Dividend metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
Dividend Yield (TTM)	2.22%	0.00%
Dividend Payout Ratio (TTM)	92.54%	0.00%

Valuation

P/E Ratio (TTM)

Abbott Laboratories (ABT) at 41.02 is near its industry’s usual P/E ratio, while Penumbra (PEN) at 80.41 sits in the richer quartile — PEN needs stronger growth or earnings quality to justify the premium.

ABT

Health Care Equipment & Services industry group

41.02

Max: 80.41
Q3: 47.62
ABT: 41.02
Median: 29.93
Q1: 21.19
Min: 4.21

PEN

Health Care Equipment & Services industry group

80.41

PEN: 80.41
Max: 80.41
Q3: 47.62
Median: 29.93
Q1: 21.19
Min: 4.21

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their P/E ratio against the Health Care Equipment & Services industry group benchmark.

P/S Ratio (TTM)

Abbott Laboratories (ABT) at 3.95 is priced about in line with its industry on P/S ratio, while Penumbra (PEN) at 8.06 sits in the pricier quartile — PEN costs more per dollar of sales.

ABT

Health Care Equipment & Services industry group

3.95

Max: 8.80
Q3: 4.32
ABT: 3.95
Median: 2.13
Q1: 1.10
Min: 0.03

PEN

Health Care Equipment & Services industry group

8.06

Max: 8.80
PEN: 8.06
Q3: 4.32
Median: 2.13
Q1: 1.10
Min: 0.03

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their P/S ratio against the Health Care Equipment & Services industry group benchmark.

P/B Ratio (MRQ)

Abbott Laboratories (ABT) at 3.73 is valued about in line with its industry on P/B ratio, while Penumbra (PEN) at 7.95 carries an above-peer premium to book — PEN is pricier on assets.

ABT

Health Care Equipment & Services industry group

3.73

Max: 11.68
Q3: 6.12
ABT: 3.73
Median: 3.00
Q1: 1.73
Min: -1.31

PEN

Health Care Equipment & Services industry group

7.95

Max: 11.68
PEN: 7.95
Q3: 6.12
Median: 3.00
Q1: 1.73
Min: -1.31

Abbott Laboratories (ABT) vs. Penumbra (PEN): A comparison of their P/B ratio against the Health Care Equipment & Services industry group benchmark.

Valuation Metrics

Valuation metrics for Abbott Laboratories (ABT) and Penumbra (PEN)
Metric	ABT	PEN
P/E Ratio (TTM)	41.02	80.41
P/S Ratio (TTM)	3.95	8.06
P/B Ratio (MRQ)	3.73	7.95
Free Cash Flow Yield (TTM)	3.19%	1.32%